| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |